Fusion
Fusion Pharmaceuticals is a clinical-stage company focused on developing next-generation radiopharmaceuticals as precision medicines to treat cancer.
The company now trades on NASDAQ: FUSN, following its June 2020 IPO.
Fusion Pharmaceuticals is a clinical-stage company focused on developing next-generation radiopharmaceuticals as precision medicines to treat cancer.
The company now trades on NASDAQ: FUSN, following its June 2020 IPO.